TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
BXP

BXP, Inc.

Real Estate · REIT - Office

62.60$ -1.3% vs. previous close Closing price · As of: Nov 3, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios BXP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
44.5 33.6 37.9 43.4 29.9 41.0 16.8 35.7 12.5 58.0 822.6 38.7
8.2 7.9 7.6 7.7 6.4 7.2 5.3 6.2 3.4 3.4 3.4 3.1
2.5 2.5 2.4 3.5 3.0 3.8 1.8 3.1 1.3 1.9 2.2 2.1
15.9 15.0 11.4 11.5 10.3 11.1 9.7 10.5 12.3 8.1 7.9 7.4
26.7 25.1 17.4 19.2 16.1 18.8 12.6 17.1 17.3 15.6 16.5 13.3
28.4 24.5 86.3 41.8 23.2 28.5 12.7 16.1 12.0 13.5 14.9 15.5
3.5% 4.1% 1.2% 2.4% 4.3% 3.5% 7.9% 6.2% 8.3% 7.4% 6.7% 6.4%
Margins
63.9% 63.7% 63.9% 63.0% 62.4% 63.4% 62.7% 64.2% 63.5% 62.8% 61.2% 60.6%
33.5% 34.1% 32.3% 34.9% 33.6% 35.4% 32.8% 33.7% 34.1% 31.7% 30.0% 55.7%
18.5% 23.4% 20.0% 17.8% 21.5% 17.6% 31.6% 17.5% 27.3% 5.8% 0.4% 7.9%
29.0% 32.1% 8.8% 18.4% 27.6% 25.3% 41.7% 38.8% 28.4% 25.0% 23.1% 19.8%
Returns
5.6% 7.4% 6.4% 8.0% 9.9% 9.2% 10.5% 8.6% 10.1% 3.2% 0.3% 5.4%
2.2% 3.2% 2.7% 2.4% 2.9% 2.5% 3.8% 2.3% 3.5% 0.7% 0.1% 1.1%
Balance Sheet & Debt
18,411 17,694 9,746 9,837 10,464 11,499 12,241 12,444 27,514 15,523 15,037 15,131
12.9 11.9 5.8 6.3 6.0 6.6 5.7 7.0 12.5 9.1 9.3 7.8
39.7% 42.9% 42.1% 30.0% 29.0% 26.7% 36.5% 26.1% 34.6% 22.6% 20.8% 19.7%
2.6 2.3 1.3 1.8 1.9 2.1 1.7 2.2 3.4 2.9 3.0 3.2
Per Share
2.89 3.79 3.32 3.00 3.77 3.37 5.61 3.23 5.40 1.21 0.09 1.74
15.64 16.19 16.57 16.85 17.57 19.11 17.78 18.47 19.78 20.82 21.60 21.92
51.55 51.27 51.50 37.66 38.03 36.70 53.67 37.37 53.27 37.44 34.31 32.40
4.54 5.20 1.46 3.11 4.85 4.83 7.42 7.16 5.63 5.21 4.98 4.34

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?